Literature DB >> 32297040

A decade after the emergence of Candida auris: what do we know?

Amira ElBaradei1,2.   

Abstract

Candida auris is a remarkable emerging pathogen. It has emerged separately, yet simultaneously in different parts of the world, establishing four phylogenetic and geographic distinct clades with a potential fifth clade that was recently reported. C. auris is often perceived as a pathogen in disguise, due to its frequent misidentification and its immune evasion. On the other hand, many of the recovered isolates are multidrug-resistant. In fact, some of these isolates are resistant to the three main antifungal classes: echinocandins, azoles, and polyenes. Moreover, C. auris has the ability to persist and survive on different objects for a long time, aided by different adhering mechanisms including aggregation and biofilm formation, thereby causing outbreaks of invasive infections in hospital settings. However, C. auris ability to maintain its pathogenicity at high temperatures remains among its most unique properties. This is why C. auris represents a challenging threat, and more studies are needed to meet this challenge. This review highlights different characteristics of this emerging yeast with emphasis on its antifungal resistance, its ability to persistent on different surfaces, and its immune evasion capability.

Entities:  

Keywords:  Antifungal resistance; Biofilm formation; Candida auris; ERG11; FKS1; NETs

Mesh:

Substances:

Year:  2020        PMID: 32297040     DOI: 10.1007/s10096-020-03886-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  5 in total

1.  Activity and substrate specificity of Candida, Aspergillus, and Coccidioides Tpt1: essential tRNA splicing enzymes and potential anti-fungal targets.

Authors:  Swathi Dantuluri; Beate Schwer; Leonora Abdullahu; Masad J Damha; Stewart Shuman
Journal:  RNA       Date:  2021-01-28       Impact factor: 4.942

2.  Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella.

Authors:  Victor Garcia-Bustos; Javier Pemán; Alba Ruiz-Gaitán; Marta Dafne Cabañero-Navalon; Ana Cabanilles-Boronat; María Fernández-Calduch; Lucía Marcilla-Barreda; Ignacio A Sigona-Giangreco; Miguel Salavert; María Ángeles Tormo-Mas; Amparo Ruiz-Saurí
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

3.  A Preliminary in vitro and in vivo Evaluation of the Effect and Action Mechanism of 17-AAG Combined With Azoles Against Azole-Resistant Candida spp.

Authors:  Luyao Liu; Xueying Zhang; Shruti Kayastha; Lihua Tan; Heng Zhang; Jingwen Tan; Linyun Li; Jinghua Mao; Yi Sun
Journal:  Front Microbiol       Date:  2022-07-07       Impact factor: 6.064

Review 4.  Candida auris: Diagnostic Challenges and Emerging Opportunities for the Clinical Microbiology Laboratory.

Authors:  C Keighley; K Garnham; S A J Harch; M Robertson; K Chaw; J C Teng; S C-A Chen
Journal:  Curr Fungal Infect Rep       Date:  2021-06-23

5.  HPLC Method Validated for Quantification of Fluconazole Co-Encapsulated with Propolis Within Chitosan Nanoparticles.

Authors:  Jacqueline Teixeira da Silva; Matheus Gabriel de Oliveira; José Realino de Paula; Suzana Ferreira Alves; Flavio Pellegrini; Andre Correa Amaral
Journal:  Indian J Microbiol       Date:  2021-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.